0000014272-16-000294.txt : 20160219
0000014272-16-000294.hdr.sgml : 20160219
20160219163234
ACCESSION NUMBER: 0000014272-16-000294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160217
FILED AS OF DATE: 20160219
DATE AS OF CHANGE: 20160219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEUNG SANDRA
CENTRAL INDEX KEY: 0001199294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 161442259
MAIL ADDRESS:
STREET 1: C/O BRISTOL MYERS SQUIBB CO
STREET 2: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10164
4
1
wf-form4_145591753524769.xml
FORM 4
X0306
4
2016-02-17
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001199294
LEUNG SANDRA
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
1
0
0
EVP, General Counsel
Common Stock, $0.10 par value
2016-02-17
4
M
0
14560
22.73
A
319698.7417
D
Common Stock, $0.10 par value
2016-02-17
4
S
0
10152
63.568
D
309546.7417
D
Common Stock, $0.10 par value
5698.9742
I
By BMY Savings and Investment Program
Option (right to buy)
22.73
2016-02-17
4
M
0
14560
0
D
2016-03-06
Common Stock, $0.10 par value
14560.0
0
D
A portion of these shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.56 to $63.57, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Based on a plan statement as of the end of the most recent fiscal quarter.
All of the shares are currently exercisable.
/s/ Katherine Kelly, attorney-in-fact for Sandra Leung
2016-02-19